Scarica l'app Stockscreener
20.63
0.05%
0.010
Dopo l'orario di chiusura:
20.50
-0.13
-0.63%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$20.62
Aprire:
$20.96
Volume 24 ore:
1.01M
Relative Volume:
1.25
Capitalizzazione di mercato:
$1.54B
Reddito:
$384.03M
Utile/perdita netta:
$38.65M
Rapporto P/E:
66.55
EPS:
0.31
Flusso di cassa netto:
$196.35M
1 W Prestazione:
-0.53%
1M Prestazione:
-7.41%
6M Prestazione:
-3.60%
1 anno Prestazione:
+11.21%
Intervallo 1D:
$20.30
$21.00
Intervallo di 1 settimana:
$20.30
$21.41
Portata 52W:
$16.52
$22.76
Innoviva Inc Stock (INVA) Company Profile
Nome
Innoviva Inc
Settore
Industria
Telefono
(650) 238-9600
Indirizzo
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Confronta INVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
20.63 | 1.54B | 384.03M | 38.65M | 196.35M | 0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Goldman | Sell |
| 2025-08-11 | Iniziato | Oppenheimer | Outperform |
| 2025-07-14 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Iniziato | Goldman | Neutral |
| 2017-11-20 | Iniziato | Deutsche Bank | Hold |
Mostra tutto
Innoviva Inc Borsa (INVA) Ultime notizie
Innoviva, Inc. (NASDAQ:INVA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
US FDA approves Innoviva’s oral antibiotic for gonorrhea - Northland News Radio
US FDA approves Innoviva's oral antibiotic for gonorrhea - Reuters
Innoviva (NASDAQ: INVA) gets FDA approval for single-dose oral antibiotic NUZOLVENCE for gonorrhea - Stock Titan
Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea - BioSpace
Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 - PharmiWeb.com
Trading the Move, Not the Narrative: (INVA) Edition - news.stocktradersdaily.com
Innoviva, Inc. $INVA Shares Bought by Marshall Wace LLP - MarketBeat
State Board of Administration of Florida Retirement System Cuts Stake in Innoviva, Inc. $INVA - MarketBeat
Edgestream Partners L.P. Invests $763,000 in Innoviva, Inc. $INVA - Defense World
Innoviva, Inc. $INVA Shares Acquired by Quantbot Technologies LP - MarketBeat
Innoviva, Inc. $INVA Shares Purchased by Arrowstreet Capital Limited Partnership - Defense World
Net current asset value per share of Innoviva, Inc. – SWB:HVE - TradingView
How rising interest rates impact Innoviva Inc. stockTrade Entry Summary & Weekly High Momentum Picks - Newser
Why Innoviva Inc. (HVE) stock trades below fair valuePortfolio Return Report & Free Accurate Trade Setup Notifications - Newser
Can Innoviva Inc. stock surprise with earnings upsideMarket Weekly Review & Weekly Momentum Picks - Newser
Is Innoviva Inc. (HVE) stock resilient in recession scenariosShare Buyback & Growth Focused Stock Pick Reports - Newser
Can Innoviva Inc. (HVE) stock survive global slowdownBuy Signal & Verified Short-Term Plans - Newser
Innoviva Reports Strong Q3 2025 Financial Results - MSN
Will Innoviva Inc. (HVE) stock outperform small cap peersWeekly Profit Analysis & Consistent Return Investment Signals - Newser
Universal Beteiligungs und Servicegesellschaft mbH Has $247,000 Holdings in Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. $INVA Holdings Lifted by Creative Planning - MarketBeat
Innoviva, Inc. $INVA Shares Purchased by American Century Companies Inc. - MarketBeat
Boston Partners Boosts Holdings in Innoviva, Inc. $INVA - Defense World
Geode Capital Management LLC Purchases 102,194 Shares of Innoviva, Inc. $INVA - MarketBeat
Envestnet Asset Management Inc. Sells 2,386 Shares of Innoviva, Inc. $INVA - Defense World
(INVA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Jefferies Financial Group Inc. Increases Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo Finance
Franklin Resources Inc. Reduces Holdings in Innoviva, Inc. $INVA - MarketBeat
Armata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update (PR Newswire) - Aktiellt
Will Innoviva Inc. stock attract ESG investorsWeekly Profit Summary & Weekly Breakout Watchlists - moha.gov.vn
Innoviva to Participate in the 37th Annual Piper Sandler Healthcare Conference - Business Wire
CFO Basso Surrenders 237 Of Innoviva Inc [INVA] - TradingView
How robust is Innoviva Inc. (HVE) stock financial positionJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
Will Innoviva Inc. (HVE) stock draw ESG focused fundsJuly 2025 PreEarnings & Capital Efficient Trade Techniques - newser.com
How buybacks impact Innoviva Inc. stock valueBond Market & Fast Entry and Exit Trade Plans - newser.com
How Innoviva Inc. (HVE) stock trades after rate cuts2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com
How institutional ownership impacts Innoviva Inc. stock2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - newser.com
FDA Verdict Looms: Is Zoliflodacin Poised To Transform Gonorrhea Treatment? - RTTNews
Using data filters to optimize entry into Innoviva Inc.Portfolio Gains Summary & Real-Time Market Trend Scan - newser.com
Will Innoviva Inc. stock deliver better than expected guidanceJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Innoviva Inc. stock outlook for YEARBear Alert & Fast Moving Stock Trade Plans - newser.com
What is the fair value estimate for Innoviva Inc. (HVE) stock in 2025Trade Signal Summary & High Win Rate Trade Tips - newser.com
Innoviva Inc. recovery potential after sell offPortfolio Risk Summary & Growth Focused Stock Reports - newser.com
Is Innoviva Inc. still worth holding after the dipJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com
What sentiment indicators say about Innoviva Inc. stockVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com
What technical models suggest about Innoviva Inc.’s comebackWeekly Profit Summary & Weekly Momentum Picks - newser.com
Is Innoviva Inc. (HVE) stock at risk of policy regulationInflation Watch & Expert Approved Trade Ideas - newser.com
Innoviva Inc Azioni (INVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Innoviva Inc Azioni (INVA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):